Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$866,807
-$120,598 QoQ
Shares Held
35,997
+2.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,410
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COZAD ASSET MANAGEMENT INC holds $35,468,302 across 7 Drug Manufacturers - General names. PFE ranks #3 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
23,746 | $28,481,667 | |
| 2 | JNJ |
Johnson & Johnson
|
17,475 | $4,438,125 | |
| 3 | PFE |
Pfizer Inc
This page
|
35,997 | $866,807 | |
| 4 | AMGN |
Amgen Inc
|
1,667 | $603,654 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,012 | $506,876 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,019 | $346,814 | |
| 7 | NVO |
Novo Nordisk A S
|
4,680 | $224,359 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $866,807 | 35,997 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $987,405 | 35,164 | Shares | Sole | 2026-05-28 | |
| 2025-12-31 | $876,529 | 35,202 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $920,617 | 36,131 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $923,204 | 38,086 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $926,861 | 36,577 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $913,268 | 34,424 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,275,790 | 44,084 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,242,787 | 44,417 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,216,476 | 43,837 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,117,973 | 38,832 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,346,005 | 40,579 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,443,394 | 39,351 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $1,772,964 | 43,455 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $4,037,609 | 78,798 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,103,371 | 70,918 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $3,948,450 | 75,309 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,857,486 | 74,512 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $3,921,982 | 66,418 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $2,842,229 | 66,083 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,575,279 | 65,763 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,556,968 | 70,576 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,464,687 | 66,957 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,739,872 | 74,656 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $2,613,582 | 79,926 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $2,626,994 | 80,484 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||